About this trial
The RESTORE Stroke Study will evaluate the safety and effectiveness of DBS+Rehab for treating arm weakness and reduced function after a stroke.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Ischemic stroke, with an initial incident occurring between 12 months to 6 years before implant, resulting in residual upper extremity hemiparesis.
Disqualifiers
Previous or subsequent cerebrovascular events resulting in residual upper extremity impairment
Brain lesions with significant involvement of the brainstem, cerebellum, or thalamus
Trial design
Parallel
Treatments tested in this trial
Deep Brain Stimulation
DeviceDeep Brain Stimulation (DBS) of the dentate nucleus area of the cerebellum plus motor rehabilitation to improve upper-extremity function.
Rehabilitation
Other interventionMotor rehabilitation to improve upper-extremity function.
Treatment groups
Trial outcomes
Primary outcomes
Fugl-Meyer Assessment, Upper Extremity sub-scale (FMA-UE)
The change in FMA-UE is significantly greater for subjects who receive Test treatment (Tt) than Control treatment (Ct).
Secondary outcomes
Fugl-Meyer Assessment, Upper Extremity sub-scale (FMA-UE)
The change in FMA-UE for subjects who receive Test treatment (Tt) is significantly above a clinically important difference (CID)
Other outcomes
Fugl-Meyer Assessment, Upper Extremity sub-scale (FMA-UE)
Exploratory endpoints will be examined for the group originally assigned to Control treatment after crossover.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.